Novel Triterpenone for Treatment of Viral Diseases-HIV Inhibitors.
作者信息
Kargbo Robert B
机构信息
Usona Institute, 277 Granada Drive, San Luis Obispo, California 93401-7337, United States.
出版信息
ACS Med Chem Lett. 2018 Mar 14;9(4):298-299. doi: 10.1021/acsmedchemlett.8b00113. eCollection 2018 Apr 12.
Abstract
摘要
相似文献
1
Novel Triterpenone for Treatment of Viral Diseases-HIV Inhibitors.用于治疗病毒性疾病的新型三萜烯酮——HIV抑制剂
ACS Med Chem Lett. 2018 Mar 14;9(4):298-299. doi: 10.1021/acsmedchemlett.8b00113. eCollection 2018 Apr 12.
2
Emerging drug targets for antiretroviral therapy.抗逆转录病毒疗法的新兴药物靶点
Drugs. 2005;65(13):1747-66. doi: 10.2165/00003495-200565130-00002.
3
The HIV entry inhibitors revisited.再谈HIV进入抑制剂
Curr Med Chem. 2006;13(8):911-34. doi: 10.2174/092986706776361030.
4
New developments in anti-HIV chemotherapy.抗HIV化疗的新进展
Curr Med Chem. 2001 Nov;8(13):1543-72. doi: 10.2174/0929867013371842.
5
Design and Characterization of Cholesterylated Peptide HIV-1/2 Fusion Inhibitors with Extremely Potent and Long-Lasting Antiviral Activity.胆固醇化肽 HIV-1/2 融合抑制剂的设计与表征：具有极强和持久的抗病毒活性。
J Virol. 2019 May 15;93(11). doi: 10.1128/JVI.02312-18. Print 2019 Jun 1.
6
HIV type 1 integrase inhibitors: from basic research to clinical implications.1型人类免疫缺陷病毒整合酶抑制剂：从基础研究到临床应用
AIDS Rev. 2008 Jul-Sep;10(3):172-89.
7
New anti-HIV agents and targets.新型抗HIV药物及靶点。
Med Res Rev. 2002 Nov;22(6):531-65. doi: 10.1002/med.10021.
8
A New Quinoline BRD4 Inhibitor Targets a Distinct Latent HIV-1 Reservoir for Reactivation from Other "Shock" Drugs.一种新型喹啉类 BRD4 抑制剂，针对潜伏 HIV-1 储库的另一个不同靶点，可被其他“休克”药物激活。
J Virol. 2018 Apr 27;92(10). doi: 10.1128/JVI.02056-17. Print 2018 May 15.
9
Design of Novel HIV-1/2 Fusion Inhibitors with High Therapeutic Efficacy in Rhesus Monkey Models.新型 HIV-1/2 融合抑制剂的设计，在恒河猴模型中具有高治疗疗效。
J Virol. 2018 Jul 31;92(16). doi: 10.1128/JVI.00775-18. Print 2018 Aug 15.
10
Novel compounds in preclinical/early clinical development for the treatment of HIV infections.处于临床前/早期临床开发阶段用于治疗HIV感染的新型化合物。
Rev Med Virol. 2000 Jul-Aug;10(4):255-77. doi: 10.1002/1099-1654(200007/08)10:4<255::aid-rmv282>3.0.co;2-6.
引用本文的文献
1
Computational investigation of unsaturated ketone derivatives as MAO-B inhibitors by using QSAR, ADME/Tox, molecular docking, and molecular dynamics simulations.通过定量构效关系（QSAR）、药物代谢动力学/毒理学（ADME/Tox）、分子对接和分子动力学模拟对不饱和酮衍生物作为单胺氧化酶-B（MAO-B）抑制剂进行计算研究。
Turk J Chem. 2021 Dec 18;46(3):687-703. doi: 10.55730/1300-0527.3360. eCollection 2022.
2
Recent advances in natural anti-HIV triterpenoids and analogs.天然抗 HIV 三萜及其类似物的最新进展。
Med Res Rev. 2020 Nov;40(6):2339-2385. doi: 10.1002/med.21708. Epub 2020 Jul 14.
本文引用的文献
1
Adherence Measurements in HIV: New Advancements in Pharmacologic Methods and Real-Time Monitoring.HIV 患者用药依从性的检测：药理学方法和实时监测的新进展。
Curr HIV/AIDS Rep. 2018 Feb;15(1):49-59. doi: 10.1007/s11904-018-0377-0.
2
Where are we with injectables against HIV infection and what are the remaining challenges?我们在抗 HIV 感染的注射剂方面进展如何，还有哪些挑战尚未解决？
Expert Rev Anti Infect Ther. 2018 Feb;16(2):143-152. doi: 10.1080/14787210.2018.1430570. Epub 2018 Jan 25.
3
Active ingredients of a person-centred intervention for people on HIV treatment: analysis of mixed methods trial data.以人为中心的干预措施对接受 HIV 治疗人群的有效成分：混合方法试验数据的分析。
BMC Infect Dis. 2018 Jan 10;18(1):27. doi: 10.1186/s12879-017-2900-0.
4
Chimeric antigen receptor engineered stem cells: a novel HIV therapy.嵌合抗原受体工程化干细胞：一种新型的艾滋病治疗方法。
Immunotherapy. 2017 Mar;9(5):401-410. doi: 10.2217/imt-2016-0121.
5
Early infant diagnosis of HIV: review of current and innovative practices.婴儿早期HIV诊断：当前及创新实践综述
Curr Opin HIV AIDS. 2017 Mar;12(2):112-116. doi: 10.1097/COH.0000000000000343.
Zotero 插件